[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-what-is-hc-wainwrights-estimat330195948d-9118-7a75-adfe-f9d82ad213bf":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23},"what-is-hc-wainwrights-estimat330195948d-9118-7a75-adfe-f9d82ad213bf","1741952639000","What is HC Wainwright's Estimate for ONCY FY2027 Earnings?","Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) -  HC Wainwright upped their FY2027 earnings per share (EPS) estimates for Oncolytics Biotech  in a research report issued on  Monday, March 10th. HC Wainwright analyst P. Trucchio now expects that the company will earn ($0.08) per share for the ye","https://www.marketbeat.com/instant-alerts/what-is-hc-wainwrights-estimate-for-oncy-fy2027-earnings-2025-03-13/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"\",\"-\"]","[{\"name\":\"\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/blockchains/.png\"},{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","1"]